CBD Companies Beware: FTC Threatens Civil Penalties for Unsubstantiated Claims April 19, 2023 AggregatedNews Hemp Policy & Legal 0 Comments by Griffin Thorne, Attorney at Harris Bricken Marketing CBD products is a challenge. For years we’ve written about risks associated with making health-related claims in marketing. But there’s another avenue that the federal government doesn’t like: unsubstantiated claims. Last week, the Federal… Read More→
The FTC, CBD, Consumer Safety and Refunds August 29, 2022 Hilary Bricken Hemp Policy & Legal 0 Comments By Hilary Bricken, Principal at Harris Bricken I’m guilty of dunking on the Federal Trade Commission (FTC) in the past for not doing more to protect cannabis consumers, despite the current federal illegality of cannabis. That may be changing, at… Read More→
FTC Cannabis Litigation Picks Up Steam April 11, 2022 AggregatedNews Hemp Policy & Legal 0 Comments by Jihee Ahn, Attorney at Harris Bricken The days where the Federal Trade Commission (FTC) pays no mind to cannabis businesses (marijuana and hemp) are long gone. These days, the FTC is treating consumer complaints regarding hemp and marijuana businesses… Read More→
Class Actions Increasingly Targeting Cannabis Companies July 12, 2021 Julie Hussey Policy & Legal 1 Comment by Julie Hussey, Barak Cohen, Tommy Tobin Recent years have seen increased growth for cannabis companies, especially as the market for THC products continues to expand. But this growth brings with it increasing scrutiny of the industry by regulators and… Read More→
Will the FTC Adopt Less Stringent Substantiation Requirements for CBD Claims? February 25, 2021 AggregatedNews Hemp Policy & Legal 0 Comments by Natalie Bougenies, Attorney at Harris Bricken If you follow our blog, you know we keep a close eye on enforcement actions taken by the Food and Drug Administration (the FDA) and the Federal Trade Commission (the FTC or the… Read More→
FTC Announces Crackdown on Deceptively Marketed CBD Products December 18, 2020 Press Release Federal 0 Comments PRESS RELEASE Companies made unsupported claims that their oils, balms, gummies, coffee, and other goods could treat serious diseases such as cancer and diabetes The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the… Read More→
Federal Antitrust Scrutiny and (Certain) Cannabis Deal November 6, 2019 Hilary Bricken Policy & Legal 0 Comments By Hilary Bricken, Co-Founder Harris Bricken If you follow state-by-state legal cannabis legalization, you’re aware that despite the federal illegality of cannabis, certain federal agencies police the cannabis industry like they do any other legal industry. For example, the NLRB… Read More→
VDACS Okays Manufacture of CBD Products Intended for Human Consumption July 25, 2019 Kaitlyn O'Connor Virginia 0 Comments The Virginia Department of Agriculture and Consumer Services (“VDACS”) Commissioner Jewel Bronaugh sent a letter (the “July Letter”) to all Virginia-registered Industrial Hemp Processors (“Processors”) on July 15, 2019 notifying the Processors that Governor Northam’s office has directed VDACS to… Read More→
FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing April 3, 2019 Ian Stewart Policy & Legal, Spotlight 0 Comments By Ian Stewart & Neil Willner Attorneys at Wilson Elser On April 2, 2019, the U.S. Food and Drug Administration (FDA) issued a sweeping press release from outgoing Commissioner Scott Gottlieb covering new steps to advance the agency’s continued evaluation… Read More→